ID PRD15_HUMAN Reviewed; 1507 AA. AC P57071; E9PDJ6; E9PF37; E9PGL3; Q4W8S0; Q4W8S3; Q4W8S4; Q4W8S5; Q8N0X3; AC Q8NEX0; Q9NQV3; DT 01-DEC-2000, integrated into UniProtKB/Swiss-Prot. DT 28-NOV-2006, sequence version 4. DT 24-JAN-2024, entry version 205. DE RecName: Full=PR domain zinc finger protein 15 {ECO:0000305}; DE EC=2.1.1.- {ECO:0000305}; DE AltName: Full=PR domain-containing protein 15 {ECO:0000305}; DE AltName: Full=Zinc finger protein 298; GN Name=PRDM15 {ECO:0000312|HGNC:HGNC:13999}; GN Synonyms=C21orf83 {ECO:0000312|HGNC:HGNC:13999}, GN ZNF298 {ECO:0000312|HGNC:HGNC:13999}; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RX PubMed=12036298; DOI=10.1006/geno.2002.6782; RA Gardiner K., Slavov D., Bechtel L., Davisson M.; RT "Annotation of human chromosome 21 for relevance to Down syndrome: gene RT structure and expression analysis."; RL Genomics 79:833-843(2002). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3; 4 AND 5), VARIANT PRO-1481, RP SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE. RC TISSUE=Thymus; RX PubMed=15904895; DOI=10.1016/j.bbrc.2005.04.159; RA Shibuya K., Kudoh J., Okui M., Shimizu N.; RT "Identification of a novel zinc finger protein gene (ZNF298) in the GAP2 of RT human chromosome 21q."; RL Biochem. Biophys. Res. Commun. 332:557-568(2005). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=10830953; DOI=10.1038/35012518; RA Hattori M., Fujiyama A., Taylor T.D., Watanabe H., Yada T., Park H.-S., RA Toyoda A., Ishii K., Totoki Y., Choi D.-K., Groner Y., Soeda E., Ohki M., RA Takagi T., Sakaki Y., Taudien S., Blechschmidt K., Polley A., Menzel U., RA Delabar J., Kumpf K., Lehmann R., Patterson D., Reichwald K., Rump A., RA Schillhabel M., Schudy A., Zimmermann W., Rosenthal A., Kudoh J., RA Shibuya K., Kawasaki K., Asakawa S., Shintani A., Sasaki T., Nagamine K., RA Mitsuyama S., Antonarakis S.E., Minoshima S., Shimizu N., Nordsiek G., RA Hornischer K., Brandt P., Scharfe M., Schoen O., Desario A., Reichelt J., RA Kauer G., Bloecker H., Ramser J., Beck A., Klages S., Hennig S., RA Riesselmann L., Dagand E., Wehrmeyer S., Borzym K., Gardiner K., RA Nizetic D., Francis F., Lehrach H., Reinhardt R., Yaspo M.-L.; RT "The DNA sequence of human chromosome 21."; RL Nature 405:311-319(2000). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT PRO-1481. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [MRNA] OF 1-951 (ISOFORM 1). RA Yang X.-H., Huang S.; RT "A family of novel PR-domain (PRDM) genes as candidate tumor suppressors."; RL Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases. RN [6] RP NUCLEOTIDE SEQUENCE [MRNA] OF 1136-1507 (ISOFORMS 1/2), AND VARIANT RP PRO-1481. RX PubMed=12036297; DOI=10.1006/geno.2002.6781; RA Reymond A., Camargo A.A., Deutsch S., Stevenson B.J., Parmigiani R.B., RA Ucla C., Bettoni F., Rossier C., Lyle R., Guipponi M., de Souza S., RA Iseli C., Jongeneel C.V., Bucher P., Simpson A.J.G., Antonarakis S.E.; RT "Nineteen additional unpredicted transcripts from human chromosome 21."; RL Genomics 79:824-832(2002). RN [7] RP SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-883, AND IDENTIFICATION BY MASS RP SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=25755297; DOI=10.1074/mcp.o114.044792; RA Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V., RA Vertegaal A.C.; RT "System-wide analysis of SUMOylation dynamics in response to replication RT stress reveals novel small ubiquitin-like modified target proteins and RT acceptor lysines relevant for genome stability."; RL Mol. Cell. Proteomics 14:1419-1434(2015). RN [8] RP FUNCTION. RX PubMed=28740264; DOI=10.1038/ng.3922; RA Mzoughi S., Zhang J., Hequet D., Teo S.X., Fang H., Xing Q.R., Bezzi M., RA Seah M.K.Y., Ong S.L.M., Shin E.M., Wollmann H., Wong E.S.M., RA Al-Haddawi M., Stewart C.L., Tergaonkar V., Loh Y.H., Dunn N.R., RA Messerschmidt D.M., Guccione E.; RT "PRDM15 safeguards naive pluripotency by transcriptionally regulating WNT RT and MAPK-ERK signaling."; RL Nat. Genet. 49:1354-1363(2017). RN [9] RP SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-883, AND IDENTIFICATION BY MASS RP SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=28112733; DOI=10.1038/nsmb.3366; RA Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C., RA Nielsen M.L.; RT "Site-specific mapping of the human SUMO proteome reveals co-modification RT with phosphorylation."; RL Nat. Struct. Mol. Biol. 24:325-336(2017). CC -!- FUNCTION: Sequence-specific DNA-binding transcriptional regulator. CC Plays a role as a molecular node in a transcriptional network CC regulating embryonic development and cell fate decision. Stimulates the CC expression of upstream key transcriptional activators and repressors of CC the Wnt/beta-catenin and MAPK/ERK pathways, respectively, that are CC essential for naive pluripotency and self-renewal maintenance of CC embryonic stem cells (ESCs). Specifically promotes SPRY1 and RSPO1 CC transcription activation through recognition and direct binding of a CC specific DNA sequence in their promoter regions. Involved in early CC embryo development (By similarity). Also plays a role in induced CC pluripotent stem cells (iPSCs) reprogramming (PubMed:28740264). CC {ECO:0000250|UniProtKB:E9Q8T2, ECO:0000269|PubMed:28740264}. CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15904895}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=5; CC Name=1; CC IsoId=P57071-1; Sequence=Displayed; CC Name=2; Synonyms=ZNF298b; CC IsoId=P57071-2; Sequence=VSP_055110, VSP_055111, VSP_055113; CC Name=3; Synonyms=ZNF298a; CC IsoId=P57071-3; Sequence=VSP_055110, VSP_055111; CC Name=4; Synonyms=ZNF298c; CC IsoId=P57071-5; Sequence=VSP_055110, VSP_055111, VSP_055114, CC VSP_055117; CC Name=5; Synonyms=ZNF298d; CC IsoId=P57071-6; Sequence=VSP_055110, VSP_055111, VSP_055112, CC VSP_055115, VSP_055116; CC -!- TISSUE SPECIFICITY: Detected in all tissues examined. CC {ECO:0000269|PubMed:15904895}. CC -!- DEVELOPMENTAL STAGE: Expressed in fetal tissues. CC {ECO:0000269|PubMed:15904895}. CC -!- MISCELLANEOUS: [Isoform 4]: May be produced at very low levels due to a CC premature stop codon in the mRNA, leading to nonsense-mediated mRNA CC decay. {ECO:0000305}. CC -!- MISCELLANEOUS: [Isoform 5]: May be produced at very low levels due to a CC premature stop codon in the mRNA, leading to nonsense-mediated mRNA CC decay. {ECO:0000305}. CC -!- SIMILARITY: Belongs to the class V-like SAM-binding methyltransferase CC superfamily. {ECO:0000255|PROSITE-ProRule:PRU00190}. CC -!- SEQUENCE CAUTION: CC Sequence=AAL60596.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305}; CC Sequence=AAM53515.1; Type=Erroneous translation; Note=Erroneous CDS prediction.; Evidence={ECO:0000305}; CC Sequence=AAM53516.1; Type=Erroneous translation; Note=Erroneous CDS prediction.; Evidence={ECO:0000305}; CC Sequence=BAA95527.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305}; CC Sequence=BAD99015.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305}; CC Sequence=BAD99016.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305}; CC Sequence=BAD99017.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305}; CC Sequence=BAD99018.1; Type=Erroneous translation; Note=Erroneous CDS prediction.; Evidence={ECO:0000305}; CC Sequence=BAD99020.1; Type=Erroneous translation; Note=Erroneous CDS prediction.; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AY078498; AAL85487.2; -; mRNA. DR EMBL; AB051812; BAD99015.1; ALT_INIT; mRNA. DR EMBL; AB051813; BAD99016.1; ALT_INIT; mRNA. DR EMBL; AB051814; BAD99017.1; ALT_INIT; mRNA. DR EMBL; AB051814; BAD99018.1; ALT_SEQ; mRNA. DR EMBL; AB051815; BAD99020.1; ALT_SEQ; mRNA. DR EMBL; AB126081; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AP001580; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AP001618; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AP001619; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AP001745; BAA95527.1; ALT_SEQ; Genomic_DNA. DR EMBL; AP002955; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471079; EAX09585.1; -; Genomic_DNA. DR EMBL; AF276513; AAF78093.1; -; mRNA. DR EMBL; AY063456; AAL60596.1; ALT_INIT; mRNA. DR EMBL; AF426259; AAM53515.1; ALT_SEQ; mRNA. DR EMBL; AF426260; AAM53516.1; ALT_SEQ; mRNA. DR RefSeq; NP_001035514.1; NM_001040424.2. DR RefSeq; NP_001269863.1; NM_001282934.1. DR RefSeq; NP_071398.3; NM_022115.4. DR AlphaFoldDB; P57071; -. DR BioGRID; 122024; 81. DR IntAct; P57071; 10. DR MINT; P57071; -. DR STRING; 9606.ENSP00000269844; -. DR GlyGen; P57071; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; P57071; -. DR PhosphoSitePlus; P57071; -. DR BioMuta; PRDM15; -. DR DMDM; 118572696; -. DR EPD; P57071; -. DR jPOST; P57071; -. DR MassIVE; P57071; -. DR MaxQB; P57071; -. DR PaxDb; 9606-ENSP00000269844; -. DR PeptideAtlas; P57071; -. DR ProteomicsDB; 19680; -. DR ProteomicsDB; 20018; -. DR ProteomicsDB; 20339; -. DR ProteomicsDB; 56980; -. [P57071-1] DR Pumba; P57071; -. DR Antibodypedia; 9262; 113 antibodies from 20 providers. DR DNASU; 63977; -. DR Ensembl; ENST00000269844.5; ENSP00000269844.4; ENSG00000141956.14. DR Ensembl; ENST00000398548.6; ENSP00000381556.2; ENSG00000141956.14. DR Ensembl; ENST00000422911.6; ENSP00000408592.2; ENSG00000141956.14. DR Ensembl; ENST00000449395.6; ENSP00000396943.2; ENSG00000141956.14. DR GeneID; 63977; -. DR KEGG; hsa:63977; -. DR MANE-Select; ENST00000398548.6; ENSP00000381556.2; NM_001040424.3; NP_001035514.2. DR UCSC; uc002yzo.4; human. [P57071-1] DR AGR; HGNC:13999; -. DR CTD; 63977; -. DR DisGeNET; 63977; -. DR GeneCards; PRDM15; -. DR HGNC; HGNC:13999; PRDM15. DR HPA; ENSG00000141956; Low tissue specificity. DR MIM; 617692; gene. DR neXtProt; NX_P57071; -. DR PharmGKB; PA33713; -. DR VEuPathDB; HostDB:ENSG00000141956; -. DR eggNOG; KOG1721; Eukaryota. DR InParanoid; P57071; -. DR OrthoDB; 5400229at2759; -. DR PhylomeDB; P57071; -. DR TreeFam; TF331419; -. DR PathwayCommons; P57071; -. DR SignaLink; P57071; -. DR BioGRID-ORCS; 63977; 28 hits in 1180 CRISPR screens. DR ChiTaRS; PRDM15; human. DR GenomeRNAi; 63977; -. DR Pharos; P57071; Tbio. DR PRO; PR:P57071; -. DR Proteomes; UP000005640; Chromosome 21. DR RNAct; P57071; Protein. DR Bgee; ENSG00000141956; Expressed in sural nerve and 152 other cell types or tissues. DR ExpressionAtlas; P57071; baseline and differential. DR Genevisible; P57071; HS. DR GO; GO:0016604; C:nuclear body; IDA:HPA. DR GO; GO:0005654; C:nucleoplasm; IDA:HPA. DR GO; GO:0005634; C:nucleus; IDA:UniProtKB. DR GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IBA:GO_Central. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW. DR GO; GO:1990841; F:promoter-specific chromatin binding; ISS:UniProtKB. DR GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISS:UniProtKB. DR GO; GO:0032259; P:methylation; IEA:UniProtKB-KW. DR GO; GO:0043409; P:negative regulation of MAPK cascade; ISS:UniProtKB. DR GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; ISS:UniProtKB. DR GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:UniProtKB. DR GO; GO:2000035; P:regulation of stem cell division; ISS:UniProtKB. DR GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central. DR CDD; cd19199; PR-SET_PRDM15; 1. DR Gene3D; 3.30.160.60; Classic Zinc Finger; 11. DR Gene3D; 2.170.270.10; SET domain; 1. DR InterPro; IPR044409; PRDM15_PR-SET. DR InterPro; IPR001214; SET_dom. DR InterPro; IPR046341; SET_dom_sf. DR InterPro; IPR036236; Znf_C2H2_sf. DR InterPro; IPR013087; Znf_C2H2_type. DR PANTHER; PTHR16515; PR DOMAIN ZINC FINGER PROTEIN; 1. DR PANTHER; PTHR16515:SF34; PR DOMAIN ZINC FINGER PROTEIN 15; 1. DR Pfam; PF21549; PRDM2_PR; 1. DR Pfam; PF00096; zf-C2H2; 6. DR SMART; SM00355; ZnF_C2H2; 17. DR SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 8. DR PROSITE; PS50280; SET; 1. DR PROSITE; PS00028; ZINC_FINGER_C2H2_1; 16. DR PROSITE; PS50157; ZINC_FINGER_C2H2_2; 13. PE 1: Evidence at protein level; KW Activator; Alternative splicing; Developmental protein; DNA-binding; KW Isopeptide bond; Metal-binding; Methyltransferase; Nucleus; KW Reference proteome; Repeat; Repressor; S-adenosyl-L-methionine; KW Transcription; Transcription regulation; Transferase; Ubl conjugation; KW Zinc; Zinc-finger. FT CHAIN 1..1507 FT /note="PR domain zinc finger protein 15" FT /id="PRO_0000047772" FT DOMAIN 415..525 FT /note="SET" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00190" FT ZN_FING 563..585 FT /note="C2H2-type 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 738..760 FT /note="C2H2-type 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 765..788 FT /note="C2H2-type 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 826..848 FT /note="C2H2-type 4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 853..875 FT /note="C2H2-type 5" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 902..924 FT /note="C2H2-type 6" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 929..951 FT /note="C2H2-type 7" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 992..1015 FT /note="C2H2-type 8" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 1020..1042 FT /note="C2H2-type 9" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 1056..1078 FT /note="C2H2-type 10" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 1084..1106 FT /note="C2H2-type 11" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 1112..1134 FT /note="C2H2-type 12" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 1140..1162 FT /note="C2H2-type 13" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 1168..1190 FT /note="C2H2-type 14" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 1196..1219 FT /note="C2H2-type 15" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 1225..1248 FT /note="C2H2-type 16" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT REGION 1..26 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 77..105 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 590..649 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 970..989 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1288..1339 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1474..1507 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 82..101 FT /note="Pro residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1488..1507 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT CROSSLNK 883 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0007744|PubMed:25755297, FT ECO:0007744|PubMed:28112733" FT VAR_SEQ 35..297 FT /note="Missing (in isoform 2, isoform 3, isoform 4 and FT isoform 5)" FT /evidence="ECO:0000303|PubMed:15904895" FT /id="VSP_055110" FT VAR_SEQ 344..409 FT /note="Missing (in isoform 2, isoform 3, isoform 4 and FT isoform 5)" FT /evidence="ECO:0000303|PubMed:15904895" FT /id="VSP_055111" FT VAR_SEQ 701..720 FT /note="Missing (in isoform 5)" FT /evidence="ECO:0000303|PubMed:15904895" FT /id="VSP_055112" FT VAR_SEQ 821 FT /note="T -> TGLIAHPGEGGPGGSRLRDLP (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15904895" FT /id="VSP_055113" FT VAR_SEQ 822..884 FT /note="DDKTFQCEMCFRFFSTNSNLSKHKKKHGDKKFACEVCSKMFYRKDVMLDHQR FT RHLEGVRRVKR -> GLIAHPGEGGPGGSRLRDLPATSPSTRRSTATRSLPVRSAARCS FT TARTSCWTTSAGTWKECGE (in isoform 4)" FT /evidence="ECO:0000303|PubMed:15904895" FT /id="VSP_055114" FT VAR_SEQ 822..864 FT /note="DDKTFQCEMCFRFFSTNSNLSKHKKKHGDKKFACEVCSKMFYR -> ATSPS FT TRRSTATRSLPVRSAARCSTARTSCWTTSAGTWKECGE (in isoform 5)" FT /evidence="ECO:0000303|PubMed:15904895" FT /id="VSP_055115" FT VAR_SEQ 865..1507 FT /note="Missing (in isoform 5)" FT /evidence="ECO:0000303|PubMed:15904895" FT /id="VSP_055116" FT VAR_SEQ 885..1507 FT /note="Missing (in isoform 4)" FT /evidence="ECO:0000303|PubMed:15904895" FT /id="VSP_055117" FT VARIANT 1342 FT /note="V -> I (in dbSNP:rs3819158)" FT /id="VAR_014992" FT VARIANT 1376 FT /note="T -> S (in dbSNP:rs2236695)" FT /id="VAR_014993" FT VARIANT 1481 FT /note="S -> P (in dbSNP:rs3850706)" FT /evidence="ECO:0000269|PubMed:12036297, FT ECO:0000269|PubMed:15904895, ECO:0000269|Ref.4" FT /id="VAR_014994" FT CONFLICT 1147 FT /note="R -> G (in Ref. 6; AAL60596)" FT /evidence="ECO:0000305" FT CONFLICT 1167 FT /note="D -> I (in Ref. 6; AAL60596)" FT /evidence="ECO:0000305" SQ SEQUENCE 1507 AA; 169269 MW; E980A7EDB97239D0 CRC64; MPRRRPPASG AAQFPERIAT RSPDPIPLCT FQRQPRAAPV QPPCRLFFVT FAGCGHRWRS ESKPGWISRS RSGIALRAAR PPGSSPPRPA APRPPPPGGV VAEAPGDVVI PRPRVQPMRV ARGGPWTPNP AFREAESWSQ IGNQRVSEQL LETSLGNEVS DTEPLSPASA GLRRNPALPP GPFAQNFSWG NQENLPPALG KIANGGGTGA GKAECGYETE SHLLEPHEIP LNVNTHKFSD CEFPYEFCTV CFSPFKLLGM SGVEGVWNQH SRSASMHTFL NHSATGIREA GCRKDMPVSE MAEDGSEEIM FIWCEDCSQY HDSECPELGP VVMVKDSFVL SRARSWPASG HVHTQAGQGM RGYEDRDRAD PQQLPEAVPA GLVRRLSGQQ LPCRSTLTWG RLCHLVAQGR SSLPPNLEIR RLEDGAEGVF AITQLVKRTQ FGPFESRRVA KWEKESAFPL KVFQKDGHPV CFDTSNEDDC NWMMLVRPAA EAEHQNLTAY QHGSDVYFTT SRDIPPGTEL RVWYAAFYAK KMDKPMLKQA GSGVHAAGTP ENSAPVESEP SQWACKVCSA TFLELQLLNE HLLGHLEQAK SLPPGSQSEA AAPEKEQDTP RGEPPAVPES ENVATKEQKK KPRRGRKPKV SKAEQPLVIV EDKEPTEQVA EIITEVPPDE PVSATPDERI MELVLGKLAT TTTDTSSVPK FTHHQNNTIT LKRSLILSSR HGIRRKLIKQ LGEHKRVYQC NICSKIFQNS SNLSRHVRSH GDKLFKCEEC AKLFSRKESL KQHVSYKHSR NEVDGEYRYR CGTCEKTFRI ESALEFHNCR TDDKTFQCEM CFRFFSTNSN LSKHKKKHGD KKFACEVCSK MFYRKDVMLD HQRRHLEGVR RVKREDLEAG GENLVRYKKE PSGCPVCGKV FSCRSNMNKH LLTHGDKKYT CEICGRKFFR VDVLRDHIHV HFKDIALMDD HQREEFIGKI GISSEENDDN SDESADSEPH KYSCKRCQLT FGRGKEYLKH IMEVHKEKGY GCSICNRRFA LKATYHAHMV IHRENLPDPN VQKYIHPCEI CGRIFNSIGN LERHKLIHTG VKSHACEQCG KSFARKDMLK EHMRVHDNVR EYLCAECGKG MKTKHALRHH MKLHKGIKEY ECKECHRRFA QKVNMLKHCK RHTGIKDFMC ELCGKTFSER NTMETHKLIH TVGKQWTCSV CDKKYVTEYM LQKHVQLTHD KVEAQSCQLC GTKVSTRASM SRHMRRKHPE VLAVRIDDLD HLPETTTIDA SSIGIVQPEL TLEQEDLAEG KHGKAAKRSH KRKQKPEEEA GAPVPEDATF SEYSEKETEF TGSVGDETNS AVQSIQQVVV TLGDPNVTTP SSSVGLTNIT VTPITTAAAT QFTNLQPVAV GHLTTPERQL QLDNSILTVT FDTVSGSAML HNRQNDVQIH PQPEASNPQS VAHFINLTTL VNSITPLGSQ LSDQHPLTWR AVPQTDVLPP SQPQAPPQQA AQPQVQAEQQ QQQMYSY //